Table 1

Overview of study patients

Pre-transplantation characteristics

Post-transplantation characteristics

Age (years)

Sex

Disease duration (years)

RF-IgM (IU/ml)

ACPA-IgG (AU/ml)

CRP (mg/l)

ESR (mm/hour)

DAS₄₄

Lowest DAS₄₄

DMARD-free days

DAS₄₄ at start or DMARDs

Patient 1

51

Female

7

575

94

12

40

5.89

0.89

423

2.62

Patient 2

43

Male

11

1,096

215

57

126

5.13

1.95

163

4.10

Patient 3

42

Female

15

500

401

50

61

4.58

1.94

738

3.40

Patient 4

35

Female

9

61

577

2

49

4.77

3.52

60

5.16

Patient 5

45

Female

12

1,656

1,014

192

113

5.49

1.82

67

3.72

Patient 6

42

Female

20

1,796

1,584

59

64

7.24

3.80

184

4.95

ESR, erythrocyte sedimentation rate; DAS₄₄, Disease Activity Score of 44 joints; DMARD, disease-modifying antirheumatic drug.

Teng et al. Arthritis Research & Therapy 2007 9:R106   doi:10.1186/ar2309